Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2012

Apr 3, 2012

33819_dirs_2012-04-03_1586df71-0efb-44c0-8c90-e1026080c591.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-04-01

Reporting Person: WEISSMAN IRVING (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-01 Common Stock A 11262 $0.00 Acquired 73179 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 19012 Indirect

Footnotes

F1: Quarterly retainer paid to Dr. Weissman in shares of common stock as consideration for his continued service on the Company's Scientific Advisory Board.

F2: Includes anniversary equity grant of 1,000 restricted stock units, vesting 100% on October 1, 2012, the one year anniversary of the grant.

F3: 10,508 shares held in trust as to which Dr. Weissman disclaims beneficial ownership.